1025 related articles for article (PubMed ID: 11329059)
41. Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2.
Zhao B; Cai J; Boulton M
Microvasc Res; 2004 Nov; 68(3):239-46. PubMed ID: 15501243
[TBL] [Abstract][Full Text] [Related]
42. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.
Luttun A; Tjwa M; Carmeliet P
Ann N Y Acad Sci; 2002 Dec; 979():80-93. PubMed ID: 12543719
[TBL] [Abstract][Full Text] [Related]
43. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
44. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
[TBL] [Abstract][Full Text] [Related]
45. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
46. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis.
Schomber T; Kopfstein L; Djonov V; Albrecht I; Baeriswyl V; Strittmatter K; Christofori G
Cancer Res; 2007 Nov; 67(22):10840-8. PubMed ID: 18006829
[TBL] [Abstract][Full Text] [Related]
47. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
48. Role of vascular endothelial growth factor in the regulation of angiogenesis.
Ferrara N
Kidney Int; 1999 Sep; 56(3):794-814. PubMed ID: 10469350
[TBL] [Abstract][Full Text] [Related]
49. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
Grunstein J; Roberts WG; Mathieu-Costello O; Hanahan D; Johnson RS
Cancer Res; 1999 Apr; 59(7):1592-8. PubMed ID: 10197634
[TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
51. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
[TBL] [Abstract][Full Text] [Related]
52. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
[TBL] [Abstract][Full Text] [Related]
53. A novel in vitro assay for human angiogenesis.
Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
[TBL] [Abstract][Full Text] [Related]
54. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.
Vacca A; Ria R; Ribatti D; Semeraro F; Djonov V; Di Raimondo F; Dammacco F
Haematologica; 2003 Feb; 88(2):176-85. PubMed ID: 12604407
[TBL] [Abstract][Full Text] [Related]
55. The effects of angiogenic growth factors on extravillous trophoblast invasion and motility.
Lash GE; Cartwright JE; Whitley GS; Trew AJ; Baker PN
Placenta; 1999 Nov; 20(8):661-7. PubMed ID: 10527820
[TBL] [Abstract][Full Text] [Related]
56. Placenta growth factor is not required for exercise-induced angiogenesis.
Gigante B; Tarsitano M; Cimini V; De Falco S; Persico MG
Angiogenesis; 2004; 7(3):277-84. PubMed ID: 15609082
[TBL] [Abstract][Full Text] [Related]
57. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
58. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
[TBL] [Abstract][Full Text] [Related]
59. Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism.
Yao YG; Yang HS; Cao Z; Danielsson J; Duh EJ
FEBS Lett; 2005 Feb; 579(5):1227-34. PubMed ID: 15710418
[TBL] [Abstract][Full Text] [Related]
60. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.
Monsky WL; Fukumura D; Gohongi T; Ancukiewcz M; Weich HA; Torchilin VP; Yuan F; Jain RK
Cancer Res; 1999 Aug; 59(16):4129-35. PubMed ID: 10463618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
